万维书刊网微信二维码

扫微信,关注编辑QQ!

投稿问答最小化  关闭

投稿有问题?问问网友吧!

我要提问

您的位置:万维书刊网 >>期刊大全 >>SCI/SCIE期刊 >>医药卫生>>内科学

Haematologica(研究方向:血液学) (官网投稿)

简介
Haematologica,出版国家为意大利。Haematologica杂志出版了血液学广泛领域的文章,报告在临床基础和翻译研究新的重要发现。Haematologica成立于1920年由Adolfo Ferrata,并于2005年合并了“血液学杂志”。Haematologica是欧洲血液学协会(EHA)的杂志,并且隶属于意大利血液学学会(SIE)和意大利实验血液学学会(SIES)。
本刊为:SCI期刊(2015-2016), SCIE期刊(2015-2016), 外文期刊,
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊官网:http://haematologica.org/

3、期刊投稿:

http://submit-haematol.highwire.org/

4、官网电话:+39 0382 27129

5、官网邮箱:office@haematologica.org

6、编辑部地址:via Giuseppe Belli 427100 Pavia,意大利

7、信息说明:本刊信息来源于网络,包括 SCI 收录核心期刊,增补期刊,期刊收录数据每年进行更新。本站是公益性网站,为网友投稿提供免费服务,由于受相关约束,我们不能提供相关期刊的影响因子、JCR期刊分区等数据供大家参考,造成不便,敬请谅解。

201738日星期三

                    

 

Guide for Authors

 

A. General information

 

Haematologica publishes articles in the broad field of hematology, reporting on novel findings in basic, clinical and translational research.

The scope of the journal is to report novel research results that have an important impact on our understanding of normal hematology or the development of hematological diseases, or are likely to bring important changes to the diagnosis or treatment of hematological diseases.

All articles are evaluated based on an international peer review process. Less than 20% of submitted articles can be accepted. Articles will be selected based on novelty, importance for the field and experimental quality.

Authors should fully disclose and provide all information on sequences, chemical structures, recombinant proteins, cell lines, datasets, etc.

We are proud to offer an easy submission system and a rapid and fair peer review with only 19 days as average time to first decision. We aim to provide a clear decision on the acceptance or rejection of a manuscript, with maximum 2 revisions, in order not to delay publication of research results. Requests for fast-track review are possible (see further down).

Haematologica is an Open Access Journal, as the Ferrata Storti Foundation and the European Hematology Association believe that works reporting the results of scientific research should be openly accessible and freely usable by the entire scientific community.

The current impact factor of Haematologica is 6.671 (JCR 2015 impact factor). Haematologica ranks number 4 of 70 hematology journals.

 

Follow us on:

 

the web: www.haematologica.org

our app: download the app from the App Store or Google Play

Facebook: www.facebook.com/haematologica

 

Manuscript submission

 

Manuscripts should be submitted through the online manuscript processing system: http://submit-haematol.highwire.org.

 

Attention: The author names and affiliations inserted in the online submission system will be those which will be published in PubMed. The Haematologica Journal staff is therefore not responsible for eventual inaccuracies or mistakes in the affiliations inserted during the submission process.

 

At initial submission, these files will be requested:

 

·one pdf file with the text, tables, and figures (please make sure the file size is below 5 Mb)

·one pdf file with all supplemental data

·Information on AUTHOR CONTRIBUTION and DISCLOSURES should be provided during online submission.

·We are very flexible on the format of the first submission - we believe that the data is important, not the format.

At submission of a revised manuscript, these files will be requested:

 

·one word document with text and tables (indicate in color the changes that were made compared to the first submission)

·single high quality files for each figure (jpg is preferred)

·one pdf file with all supplemental data

·download the checklist for the submission of a revised article or the submission of a revised letter

·at revision, we request that authors strictly follow our guidelines to ensure fast publication.

 

B. Manuscript preparation

 

1. Manuscript style

 

Manuscripts should be prepared according to the Uniform Requirements established by the International Committee of Medical Journal Editors (ICMJE): http://www.icmje.org/manuscript_1prepare.html

Manuscripts should be prepared using American English spelling, and should be submitted as Word files. Submit one manuscript file with the main text, figure legends and tables. Save your file in .doc format (not as .docx file).

Scientific nomenclatur should be used without Saxon Genitive (for example: use 'Hodgkin Lymphoma' and not 'Hodgkin's Lymphoma'). Saxon Genitive should be maintained in references.

Abbreviations or acronyms should only be used when necessary (do not use abbreviations of words that are only used once or twice in the entire text), and should be explained at their first use. Abbreviations should not be used in the title and also not in the abstract (gene symbols are allowed, common abbreviations such as 'PCR' are allowed - do not use 'AML' but use 'acute myeloid leukemia' in title and abstract).

Units and measurements: The SI system should be used for all scientific units. Please refer to http://www.bloodindex.com/normal_laboratory_values.php for hematological measures. Authors can also refer to http://www.unc.edu/~rowlett/units/scales/clinical_data.html for conversions from conventional units to SI units. Please adopt standardized abbreviations and define full forms in footnotes, e.g. “NA” (not applicable) ; “ND” (not determined).

The use of commercial names of drugs should be avoided. Drugs should only be referred to under their generic names unless different products are being compared. (for example: Use deferiprone, not Ferriprox)

Use the official gene symbols when referring to genes, transcripts, proteins. (for example: Use ABL1, not ABL or c-ABL ; use MYC, not c-Myc). Use this database as a reference: http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene. Human Genes' names have to be indicated in Italic and capital,  Human Proteins' names only in capital letter. Mouse and Rat Genes' names have to be indicated in italic, with only the first letter in capital and the remaining letters in lowercase (Shh). Mouse and Rat Proteins' names have to be indicated only in capital letter (SHH). Zebrafish and Frog (xenopus sp.) Genes' names have to be indicated in italic and all in lowercase (shh). Zebrafish and Frog (xenopus sp.) Proteins' names must have the first letter in capital and the remaining letters in lowercase.

References: Please follow the recommendations of ICMJE for the style of the references available at http://www.nlm.nih.gov/bsd/uniform_requirements.html. An Endnote style is available for download: Haematologica Endnote style (updated in 2015).

Image size and layout: Image layout should be simple, clear and precise. In order to promote good management of the space, images must take up the least space possible without compromising clarity. Figures can be either one column width (8 cm) or 2 column widths (16 cm). If the figure contains different panels their content should be identified (use capital letters to identify each panel) and described in the order in which they are presented. Please ensure that a description is provided for all parts of the figure. Please ensure that different parts of the image are shown in proportion to each other, e.g. axis scales and labels, internal descriptive text. Lines should be black (not grey) and sufficiently thick. Data which has no graphic significance to any part of the figure content and form should be presented as a separate table.

Figure quality: When a revised version of a manuscript is submitted, high quality figures will be required and will be asked to the authors. High quality figures should be submitted in jpg or tiff format. Note that we can not accept figures as presentation slides (Microsoft Powerpoint, Apple Keynote, or similar) as these can not be printed in high quality. The resolution of figures should be sufficiently high to allow clear sharp printing. The best way to determine if a figure is of sufficient quality is to print it in its final size: if all lines, letters, images are sharp and clear (not blurry or unfocused) and sufficiently large to read, then the figure is most likely fine. It is not possible to increase the quality of low quality images : be sure to capture high quality images at all times during experimental procedures. When making figures in adobe illustrator or similar software, export your figures as 300 dpi or 600 dpi jpg files (for text 600 dpi is likely to be the best option).

We can not accept low quality figures. A manuscript can not be accepted if the authors fail to provide high quality figures.

Reproductions and adaptations: The author must obtain written permission for the reproduction and adaptation of material that has already been published. Permission should be obtained from the copyright holder or publisher. Before a manuscript goes into print, Haematologica will need to receive a copy of the written permission. All material presented from other sources should be identified and should be accompanied by a specific reference in the legend confirming that permission for its use had been obtained, for example: “Adapted from Berger et al. Leukemia 2003, 17, 1820-1826; with permission.”

 

We are flexible at initial submission, but at submission of a revised manuscript these guidelines need to be followed carefully:

Download the checklist for the submission of a revised article or the submission of a revised letter.

 

2. Types of manuscripts

 

Articles are the main type of manuscripts, reporting both clinical and experimental hematology research studies that are of excellent quality and report novel findings that are of high importance for the field. These articles are to be divided into sections under the following subheadings: Abstract, Introduction, Methods, Results, Discussion, References. Results and Discussion can be combined in one section if appropriate.

The abstract should be a summary of the work in maximum 250 words. State clearly the rationale for the study, how the study was performed, the most important results obtained, and the conclusions that can be drawn from this study. Articles reporting clinical trials should provide the trial registration number at the end of the abstract.

The main text (introduction, methods, results, discussion) can be maximum 4000 words.

The methods section in the article should be a brief summary of the most important methods (maximum 500 words), and is placed after the introduction. Describe basic material (patient samples, cell lines, specific methods, special reagents, ...).

If more space is needed for the methods, this can be provided in the online supplement that will be published with the online version of the article. There is no restriction to the length of the online methods section, but avoid making this part unnecessary long.

References should be given in the correct style (see the latest issue of Haematologica for an example), with a maximum of 50 references.

Figures and tables: Original articles can contain 8 display items (figures and/or tables). Authors are requested to provide the tables as text files in the manuscript file (word file). Tables should only contain data that is essential for the manuscript. Large additional tables (for example with patient characteristics, primer sequences, etc.) should be placed in the supplement. Authors are requested to provide the figures as high resolution images (jpg or tiff – power point figures are not accepted) in the final size in which they will be published, taking the relative size of all the graphs into account, as well as the size of letters and symbols in the graphs.

All supplementary material should be prepared and submitted as one single pdf file. This file will also be reviewed by the reviewers. In case of acceptance of the manuscript, this supplemental pdf file will be published as provided by the authors (this file will not be edited by the journal office, it is the reponsibility of the authors to ensure the supplement is complete and correct).

Review articles are invited articles, direct submission without invitation is not possible. Review articles are maximum 5000 words long (excluding figure legends and references) and do not have a specific structure. The articles should contain an abstract (short summary of the topic without specific structure) of maximum 250 words, may contain several display items in color, and have a reference list of maximum 100 references. These articles should not simply go over or summarize general information which is already known, but also discuss the importance of the data and provide a clear view on how these insights have transformed or will transform the hematology field. Authors of review articles are encouraged to include 4 to 6 figures. Authors should only provide a draft of the figures (all formats acceptable), as the final high quality figures for review articles will be generated by Somersault1824 (www.somersault1824.com).

Guideline articles should consist of meta-analyses and/or guidelines carried out and prepared by an international group of experts. These articles are up to 5000 words long (excluding figure legends and references) and do not have a specific structure. The articles should contain an unstructured abstract (short summary/ introduction) of maximum 200 words, may contain several display items in color, and have a reference list of maximum 100 references.

Editorials are commentaries or opinions on specific articles or on general concepts in hematology practice or research. These articles are usually invited articles, but proposals are welcome and should be addressed to the editorial office (office@haematologica.org).  These articles have a free structure (no abstract, no specific subheadings), contain about 1,500 words (excluding references), up to 20 references and may contain two display items (figures and/or tables). Haematologica has a wide international readership both in the field of hematology and in other sectors of the medical profession. Its aim is to reach also those without specialized knowledge. Authors are asked to use simple, straightforward language to promote the understanding by all readers.

Letters to the Editor: We encourage submission of important new findings that fit into the format of a letter. Start the letter with a paragraph summarizing the rationale for the study and the major conclusions. Letters have no abstract, no headings, and a maximum of 1500 words in the text (excluding title, authors, affiliations, figures legends or references), a maximum of 3 tables and/or figures, and only 15 essential references. Letters will appear in the online version of the journal, will appear in the table of contents, and are indexed in pubmed.

Case Reports & Case Series: Detailed reports of special cases that contribute to a better mechanistic understanding of hematological diseases or to patient care will be considered for publication under 'Case Reports & Case Series'. These reports need to be conclusive and will need to describe various data (molecular data, biology data, etc.) in addition to the description of the clinical data. Only few case reports can be published and a strict selection is in place. Case Reports have no abstract, no headings, and a maximum of 1500 words in the text (excluding title, authors, affiliations, figure legends or references), a maximum of 3 tables and/or figures, and only 15 essential references. Case Reports will appear in the online version of the journal, will appear in the table of contents, and are indexed in pubmed.

Comments are the format to discuss a recently published article in Haematologica, or to discuss cutting edge ideas or developments in the broad field of hematology. Comments follow the same structure as Letters, but can not contain new data. Comments have no abstract, a maximum of 1000 words in the text (excluding title, affiliations, figures legends or references), and only 10 essential references. Please start the comment with a paragraph summarizing the rationale for the comment, citing the article or articles that form the basis for the comment. Comments will appear in the online version of the journal, will appear in the table of contents, and are indexed in pubmed.

 

Conflict of interest note:

 

Conflict of interest regarding papers that do not report original research (primary data). As detailed under Policies and Practices (http://www.haematologica.org/misc/policies.dtl) authors must disclose all relationships that could be viewed as potential conflicts of interest both in the online manuscript submission system and in the manuscript. These disclosures are expected to help readers in establishing whether the reported relationships may influence the authors’ judgment. Haematologica believes that this procedure is appropriate with respect to papers reporting original research (original articles, brief reports and research letters) as primary data speak for themselves. This procedure may be insufficient with respect to papers that do not report primary data, such as editorials, perspective articles, commentaries, review articles, guidelines, consensus papers and position papers. As stated by Kassirer & Angell [Kassirer JP, Angell M. Financial conflicts of interest in biomedical research. N Engl J Med. 1993 Aug 19;329(8):570-1. PubMed PMID: 8204121] “unlike reports of original research, these articles represent the judgment of their authors, based on their evaluation of the literature. What studies they select to discuss and their analysis of them are necessarily subjective. Bias may be extremely difficult to detect because these articles contain no primary data to speak for themselves.” Nonetheless, disclosing relationships that could be viewed as potential conflicts of interest may be acceptable in many of these papers. Haematologica, however, no longer considers for publication papers not reporting primary data - such as those listed above - whose preparation has been promoted, sponsored or supported in any way by a company whose product is discussed in the paper. In fact, the clear conflict of interest is very likely to influence judgment in these cases, and there are no primary data that can speak for themselves. This point is detailed in the online manuscript processing system; if doubts exist about this issue, the authors are invited to contact the editorial office (office@haematologica.org) before proceeding with submission.

 

3. Manuscript structure

 

3.1. Title Page

 

Information provided on the title page should correspond exactly with the information provided in the online system.

The title should consist of a phrase or a sentence; question forms should be avoided. Capitalize the first letter of the sentence only, and do not use abbreviations. Study group names may be presented in the title, however, all members’ names should be listed in an appendix and presented at the end of the main text; Add for example: A complete list of the members of the European Prospective Investigation into Cancer and Nutrition Group appears in a supplement. Acronyms such as EBMT, GOELAMS, GEIL, are acceptable. Commercial names of drugs should be avoided (use only the generic names), unless different products are being compared.

Names of authors should be presented as full first name, initial of middle name (if applicable) and full last name. Use a comma between each author, use “and” before the final author. Number authors’ affiliation in superscript. Do not include professional titles or abbreviations of qualifications or positions held.

A GROUP OF AUTHORS (CONTRIBUTORS) CREDITED UNDER ONE NAME, EITHER AS A COLLABORATION IN THE STRICTEST SENSE, OR WHEN AN ORGANIZATION, INSTITUTION, OR CORPORATION IS THE AUTHOR SHOULD BE INDICATED AS COLLABORATIVE GROUPS.

Authors’ affiliations should be provided on a new line immediately after the authors’ names. Every affiliation on a new line. Provide only the city and country (acronym for the USA countries) of each institute, not full address, the postal code is not needed.

Statement of equal authors’ contribution: In cases in which authors share equal responsibility for the study, a statement of equal contribution can be stated here. Use authors’ initials rather than full names, e.g. “GGH and FS contributed equally to this work.”

Running heads: please provide a shortened title as running head of maximum 50 characters. The use of acronyms and abbreviations is permitted.

Contact information for correspondence should confirm the name and e-mail address of the corresponding author or authors.

Word count: Provide a word count for the abstract and for the main text (= introduction + methods + results + discussion). Indicate how many tables and figures are present in the manuscript. Indicate how many supplemental files are associated with the manuscript (we request 1 supplemental pdf file ; only in specific circumstances we can accept more than 1 supplemental file).

Trial registration: Confirmation and details of trial registration should be given on the first page; please use the following form: “clinicaltrials.gov identifier: NCT00123456.”

Acknowledgments should refer to secretarial and editorial assistance, technical and intellectual input and advice, funding, fellowships and grants. The form to be used is “The authors would like to thank...”

 

编辑委员会

 

总编辑

Jan Cools(鲁汶)

 

副主编

Luca Malcovati(帕维亚)

 

总经理

Antonio Majocchi(帕维亚)

 

副主编

HélèneCavé(巴黎),Ross Levine(纽约),Claire Harrison(伦敦),Pavan Reddy(安娜堡),Andreas Rosenwald(乌尔茨堡),Juerg Schwaller(巴塞尔),Monika Engelhardt(弗莱堡),Wyndham Wilson ),Paul Kyrle(维也纳),Paolo Ghia(米兰),Swee Lay TheinBethesda),Pieter Sonneveld(鹿特丹)

 

助理编辑

Anne Freckleton(英语编辑),Rachel Stenner(英语编辑),Kate O'Donohoe(英语编辑),Ziggy Isabel Kennel(英语编辑),Cristiana Pascutto(统计顾问)

 

编辑办公室

Simona Giri(生产和市场经理),Paola Cariati(高级平面设计师),Igor Ebuli Poletti(高级平面设计师)

 

Lorella Ripari(同行评审经理),Marta Fossati(同行评审),Diana Serena Ravera(同行评审)

 

编辑委员会

Omar I. Abdel-Wahab(纽约); 波士顿杰里米·艾布拉姆森 保罗·阿罗索(布雷西亚); 拉斐尔·贝亚尔(圣地亚哥); 马尔默(Erik Berntorp)多米尼克·邦尼特(伦敦); Jean-Pierre Bourquin(苏黎世); Suzanne CannegieterLeiden; Francisco Cervantes(巴塞罗那); 尼古拉斯·基奥拉齐 Oliver Cornely(科隆); 鲁汶大学 鲁德尔韦尔(鹿特丹); Meletios A. Dimopoulos(雅典); Inderjeet Dokal(伦敦); HervéDombret(巴黎); 汉堡; 马丁·德雷林 贝尔斯达 迪米特尔·埃夫雷莫夫(罗马); 萨宾埃辛格(维也纳); 利摩日 Carlo Gambacorti-Passerini(蒙扎); 吉列尔莫加西亚马内罗(休斯顿); 克里斯蒂安·盖斯勒 皮亚罗·乔达诺 克里斯蒂安·吉塞布赖特 安德烈亚斯·格林纳赫 Hildegard Greinix(维也纳); 佩鲁贾(Paolo Gresele)托马斯·哈伯曼 克劳迪亚·哈费拉赫 奥尔良·汉斯切尔(洛桑); 克里斯汀·哈里森(南安普敦); 布赖恩·亨特利(剑桥); Ulrich Jaeger(维也纳); 贝尔斯达(Elaine Jaffe)阿尔东·卡特 加藤(匹兹堡); 克里斯托夫·克莱因 卡蒂夫 岛津岛 约翰·科斯特 罗伯特·克拉洛维奇(维也纳); RalfKüppers(埃森); Ola Landgren(纽约); 彼得·伦廷(Le Kremlin-Bicetre; Per Ljungman(斯德哥尔摩); Francesco Lo Coco(罗马); 乌特勒支(Henk M. Lokhorst)约翰·马斯卡雷尼亚斯(纽约); 玛丽亚 - 维多利亚马特奥斯(萨拉曼卡); 西蒙·门德斯费雷尔(马德里); 帕尔瓦(Giampaolo Merlini)安娜·丽塔·米利亚乔(纽约); Mohamad Mohty(南特); 海德堡(Martina Muckenthaler)安穆拉利(波士顿); 斯蒂芬·摩利根(悉尼); 德语Ott(斯图加特); Jakob Passweg(巴塞尔); Melanie Percy(爱尔兰); Rob Pieters(乌得勒支); Stefano Pileri(米兰); 米格尔·皮里斯 安德烈亚斯·赖特(曼海姆); Jose-Maria Ribera(巴塞罗那); Stefano Rivella(纽约); Francesco RodeghieroVicenza; 乌普萨拉理查德·罗森奎斯特 西蒙规则(普利茅斯); 海德堡(Claudia Scholl)马丁·施拉佩 斯巴达(巴塞尔); GérardSocié(巴黎); 塞萨洛尼基(Kostas Stamatopoulos)罗切斯特大学 波士顿马丁·斯坦伯格 阿里·塔赫尔(贝鲁特); Evangelos Terpos(雅典); 札幌市 Pieter Van VlierbergheGent; 亚历山德罗·Vannucchi(佛罗伦萨); 乔治·瓦西利乌 Edo Vellenga(格罗宁根); 乌托托维托洛(都灵); Guenter Weiss(因斯布鲁克)。安德烈亚斯·赖特(曼海姆); Jose-Maria Ribera(巴塞罗那); Stefano Rivella(纽约); Francesco RodeghieroVicenza; 乌普萨拉理查德·罗森奎斯特 西蒙规则(普利茅斯); 海德堡(Claudia Scholl)马丁·施拉佩 斯巴达(巴塞尔); GérardSocié(巴黎); 塞萨洛尼基(Kostas Stamatopoulos)罗切斯特大学 波士顿马丁·斯坦伯格 阿里·塔赫尔(贝鲁特); Evangelos Terpos(雅典); 札幌市 Pieter Van VlierbergheGent; 亚历山德罗·Vannucchi(佛罗伦萨); 乔治·瓦西利乌 Edo Vellenga(格罗宁根); 乌托托维托洛(都灵); Guenter Weiss(因斯布鲁克)。安德烈亚斯·赖特(曼海姆); Jose-Maria Ribera(巴塞罗那); Stefano Rivella(纽约); Francesco RodeghieroVicenza; 乌普萨拉理查德·罗森奎斯特 西蒙规则(普利茅斯); 海德堡(Claudia Scholl)马丁·施拉佩 斯巴达(巴塞尔); GérardSocié(巴黎); 塞萨洛尼基(Kostas Stamatopoulos)罗切斯特大学 波士顿马丁·斯坦伯格 阿里·塔赫尔(贝鲁特); Evangelos Terpos(雅典); 札幌市 Pieter Van VlierbergheGent; 亚历山德罗·Vannucchi(佛罗伦萨); 乔治·瓦西利乌 Edo Vellenga(格罗宁根); 乌托托维托洛(都灵); Guenter Weiss(因斯布鲁克)。GérardSocié(巴黎); 塞萨洛尼基(Kostas Stamatopoulos)罗切斯特大学 波士顿马丁·斯坦伯格 阿里·塔赫尔(贝鲁特); Evangelos Terpos(雅典); 札幌市 Pieter Van VlierbergheGent; 亚历山德罗·Vannucchi(佛罗伦萨); 乔治·瓦西利乌 Edo Vellenga(格罗宁根); 乌托托维托洛(都灵); Guenter Weiss(因斯布鲁克)。GérardSocié(巴黎); 塞萨洛尼基(Kostas Stamatopoulos)罗切斯特大学 波士顿马丁·斯坦伯格 阿里·塔赫尔(贝鲁特); Evangelos Terpos(雅典); 札幌市 Pieter Van VlierbergheGent; 亚历山德罗·Vannucchi(佛罗伦萨); 乔治·瓦西利乌 Edo Vellenga(格罗宁根); 乌托托维托洛(都灵); Guenter Weiss(因斯布鲁克)。

 

附属科学学会

SIE(意大利血液学学会,  www.siematologia.it

 

SIES(意大利实验血液学学会,  www.siesonline.it


投稿问答最小化  关闭

投稿有问题?问问网友吧!

问答